Triage Ventures

The name signals a systematic, high-throughput evaluation process adapted from medical triage — rapidly assessing a large volume of early-stage opportunities and directing resources toward those with the strongest vital signs. This implies a focus on capital efficiency and founder selection over thematic betting. The approach is designed for the Bay Area's hyper-competitive seed market.

Triage Ventures focuses on early-stage companies, typically at the seed and Series A stages. Check sizes in this segment of the venture market generally range from $500,000 to $3 million for initial positions, with reserves for follow-on. The firm likely aims to be among the first institutional investors at the cap table.

Triage Ventures operates as a venture capital firm, indicating a formal fund structure rather than a deal-by-deal independent sponsor model. This likely involves a traditional venture capital partnership with a management company and a committed fund vehicle. Specific fund vehicles and limited partners are not publicly disclosed.

The investment decision-makers and managing partners of Triage Ventures are not publicly identified. Given the firm's micro-VC profile, decisions likely rest with one or two founding general partners. This concentrated governance is typical of early-stage venture firms where personal conviction and direct founder relationships drive deal execution.

The firm's deal flow likely originates from the dense Bay Area network of accelerators like Y Combinator and 500 Global, angel syndicates, repeat founder referrals, and co-investor relationships with other seed-stage funds. As an early-stage specialist, personal networks and proximity to the San Francisco founder community are the primary sourcing engines rather than banker-led processes.